Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Multi-Omics Approach for Investigating Genetic and Epigenetic Mechanisms in Autism Spectrum Disorder

NCT06662591 is registered in ClinicalTrials.gov with Research and Treatment Society of Genetic Disorders as lead sponsor.

NCT NCT06662591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Multi-Omics Approach for Investigating Genetic and Epigenetic Mechanisms in Autism Spectrum Disorder
Lead sponsor
Research and Treatment Society of Genetic Disorders
Phase
Observational
Overall status
Not yet recruiting
Start date
December 27, 2025
Completion date
May 27, 2028
Enrollment
3,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder (asd)